 |
|
 Bone Metastasis (Cancer Drug Discovery and Development)
A state-of-the-art review of the molecular underpinnings of bone-seeking cancers, current treatment approaches for them, and future therapeutic strategies. The authors illuminate the role of various autocrine, paracrine, and immunological factors involved in the progression and establishment of bone metastases, highlighting the physiological... |  |  Heart Disease Diagnosis and Therapy: A Practical Approach (Contemporary Cardiology)
M. Gabriel Khan, MD, concisely assembles in a reader friendly format all the clinically useful information that an internist needs in both his daily rounds and abusy office practice to find correct clinical diagnoses and choose optimal pharmacologic therapies for their patients. Highlights include a simplified method for recognition of, and a... |  |  Gene Therapy for Cancer (Cancer Drug Discovery and Development)
The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer. Finally, in Part III, experts discuss the difficulties inherent in bringing gene therapy treatment for... |
|
 Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
This book presents an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer. It is structured in a way so readers may begin with chapters that most... |  |  Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development)
This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process.
Antiangiogenesis is a dynamic and... |  |  Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy)
Entry Inhibitors in HIV Therapy details the current status of this relatively new and very dynamic class of inhibitors. A unique overview of obstacles and accomplishments is presented. The impact of viral sequence diversity on this class of inhibitors is discussed, and a connection between basic research and clinical studies is shown. The... |
|
|
|
Result Page: 31 30 29 28 27 26 25 24 23 22 21 20 19 18 17 16 15 14 13 |